+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rotary-Cutting Biopsy System for Breast Lesion Market - Global Forecast to 2030- Product Image
Rotary-Cutting Biopsy System for Breast Lesion Market - Global Forecast to 2030- Product Image
New

Rotary-Cutting Biopsy System for Breast Lesion Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081366
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Breast lesion diagnosis has entered a new era with the introduction of rotary-cutting biopsy systems that combine precision, speed, and patient comfort. Drawing on advanced imaging guidance, these devices enable clinicians to obtain high-quality tissue samples while minimizing procedural time and discomfort. As breast cancer screening programs expand and demand for minimally invasive interventions increases, rotary-cutting technology addresses critical challenges in accuracy and workflow efficiency. Clinicians now benefit from streamlined integration with ultrasound, stereotactic, and MRI platforms, resulting in improved diagnostic confidence and faster treatment planning. With patient-centric care at the forefront, rotary-cutting biopsy has emerged as a transformative tool that elevates both clinical outcomes and operational performance across diverse care settings.

Transformative Shifts in the Breast Biopsy Landscape

Over the past decade, the breast biopsy landscape has undergone profound shifts driven by technological breakthroughs and evolving patient expectations. Image-guided procedures have moved from bulky, stationary platforms to compact, portable units that empower radiologists and surgeons to operate in ambulatory centers as effectively as in hospitals. Automation has matured, with systems transitioning from manual and semi-automatic mechanisms to fully automatic platforms that reduce human error and standardize sampling quality. Meanwhile, artificial intelligence and computer-aided detection have infiltrated pre-procedure planning, enhancing lesion targeting and reducing the number of insertions required. Reimbursement policies have shifted to reward value-based outcomes, prompting manufacturers to prioritize cost-effective disposables and streamlined workflows. Regulatory agencies now demand rigorous clinical validation, fostering partnerships between device makers and academic centers. Collectively, these trends have elevated rotary-cutting biopsy from a niche alternative to a mainstream gold standard, reshaping decision-making across the continuum of care.

Assessing the Cumulative Impact of 2025 United States Tariffs

The introduction of new tariffs in 2025 on critical components-ranging from high-precision motor assemblies to specialized imaging interfaces-has exerted upward pressure on manufacturing costs for rotary-cutting biopsy systems. Import duties on titanium needles and advanced polymer cartridges have inflated per-procedure expenses, prompting both device manufacturers and healthcare providers to reassess procurement strategies. Supply chains that once relied on single-source suppliers in Asia have fragmented, driving companies to diversify sourcing and onshore production of key subassemblies. Contract negotiations now include clauses that mitigate exposure to future trade measures. In response, some organizations have restructured pricing models, adopting subscription-style service agreements that bundle capital equipment with disposables and maintenance. Others have accelerated R&D investments to develop alternative materials or streamlined designs that sidestep high-duty components. Although short-term pricing adjustments may impact budget cycles, these strategic pivots will ultimately enhance supply resilience and protect margins.

Key Segmentation Insights Drive Targeted Strategy Development

The market’s rich tapestry of product and user segments underscores the importance of tailored strategies. Analysis by system type reveals five primary categories-core needle biopsy, excisional biopsy, fine needle aspiration, incisional biopsy, and vacuum-assisted platforms-with the incisional category further distinguished by closed versus open surgical approaches. End users span ambulatory surgical centers, diagnostic centers, hospitals, and specialty clinics; within the hospital channel, private and public institutions demonstrate distinct procurement and adoption cycles. On the product feature front, systems vary across automation levels-ranging from manual to semi-automatic and fully automatic-paired with choices in device portability, from truly mobile units to fixed consoles, and multiple needle gauge options. Applications include MRI-guided procedures, mass detection protocols, microcalcification sampling, stereotactic-guided biopsies offered with or without computer-aided detection, and ultrasound-guided techniques. Customer types encompass healthcare practitioners, physicians, radiologists, and surgeons, each influencing purchasing criteria differently. Materials such as bioabsorbable polymers, polycarbonate, stainless steel, and titanium drive performance and cost trade-offs. Distribution unfolds via direct sales, distributors, or online platforms, while procedure categories distinguish between invasive and minimally invasive techniques. Finally, radiofrequency and ultrasound represent the two leading technology platforms. Insight into these nine segmentation dimensions enables precise targeting of R&D, marketing, and operational investments, ensuring that product roadmaps and go-to-market efforts align closely with evolving clinician and facility requirements.

Regional Insights Highlight Dynamics in Major Global Markets

Regional dynamics shape adoption patterns and growth trajectories in distinct ways. In the Americas, the United States leads in procedural volume and innovation, supported by a mature reimbursement framework and high levels of private sector investment; Canada is following closely with government-driven health technology assessments that favor minimally invasive diagnostics. The Europe, Middle East & Africa region presents a mixed picture: Western Europe shows strong demand for next-generation rotary-cutting systems driven by comprehensive breast screening programs, while Middle Eastern markets are adopting premium devices to enhance medical tourism; in Africa, selective investments focus on capacity building and cost containment. Across Asia-Pacific, rapid urbanization and rising healthcare spending fuel demand in key markets such as Japan, China, Australia, and India, where portable ultrasound-guided systems are gaining traction in emerging care settings. Understanding these regional nuances equips stakeholders to tailor product features, training programs, and commercial models that resonate with local regulatory landscapes and economic realities.

Competitive Landscape: Leading Companies Shaping the Market

A small cohort of leading organizations has come to define competitive dynamics and set benchmarks for innovation and market reach. Argon Medical Devices, Inc. continues to expand its vacuum-assisted portfolio through targeted acquisitions and collaboration with academic research centers. Becton, Dickinson and Company (BD) and its C. R. Bard subsidiary lead in integrating automation with enhanced disposability features, leveraging global distribution networks to accelerate adoption. Cardinal Health, Inc. and Cook Medical Incorporated focus on deepening relationships with ambulatory surgical centers and community hospitals by offering bundled procurement and clinical education. Danaher Corporation leverages its Life Sciences division to incorporate advanced imaging interfaces and AI-driven planning tools. Devicor Medical Products, Inc. distinguishes itself with a specialized offering in excisional and open surgical systems. Multinational giants such as F. Hoffmann-La Roche AG and Hologic, Inc. pursue vertical integration by combining diagnostic assays and imaging modules with biopsy platforms. Konica Minolta, Inc. and Olympus Corporation integrate high-resolution imaging and digital pathology workflows into their systems, while Leica Biosystems Nussloch GmbH focuses on downstream tissue analysis. Medtronic plc augments its portfolio with radiofrequency-enhanced cutting modules, and United Medical Equipment, Inc. targets underserved markets with cost-effective, portable solutions. Together, these companies drive continuous product innovation, strategic partnerships, and supply chain optimization.

Actionable Recommendations to Strengthen Market Position and Drive Growth

To capitalize on current momentum, industry leaders should adopt a multi-faceted approach that addresses technology, commercialization, and supply chain resilience. First, accelerate R&D investment in modular designs and AI-powered navigation to maintain a technology edge and meet evolving clinician workflows. Second, cultivate flexible manufacturing strategies-such as dual-sourcing agreements and localized assembly facilities-to insulate against geopolitical risks and tariff fluctuations. Third, refine value-based pricing models by collaborating with payers and health systems to demonstrate cost savings through reduced repeat procedures and faster treatment initiation. Fourth, expand training and certification programs for end users, leveraging digital platforms and virtual reality simulations to drive procedural proficiency and device preference. Finally, pursue selective partnerships with imaging and pathology software providers to deliver integrated, end-to-end diagnostic solutions. By executing these recommendations, organizations will strengthen market positioning, accelerate adoption, and deliver superior patient outcomes.

Conclusion: Embracing Innovation for Improved Patient Outcomes

Rotary-cutting biopsy systems represent a pivotal advancement in breast lesion diagnostics, combining precision, speed, and patient comfort. The convergence of automation, imaging integration, and emerging materials engineering continues to redefine what clinicians expect from biopsy platforms. As tariffs reshape supply chains and reimbursement frameworks evolve to reward efficiency, manufacturers and providers must adapt by embracing flexible sourcing, dynamic pricing, and outcome-focused collaborations. By aligning product innovation with targeted segmentation insights and regional market dynamics, stakeholders can unlock new opportunities for growth while improving diagnostic accuracy and patient experiences. The collective efforts of industry leaders, clinicians, and policymakers will determine the pace at which this transformative technology becomes the standard of care.

Market Segmentation & Coverage

This research report categorizes the Rotary-Cutting Biopsy System for Breast Lesion Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Core Needle Biopsy Systems
  • Excisional Biopsy Systems
  • Fine Needle Aspiration Biopsy Systems
  • Incisional Biopsy Systems
    • Closed Biopsy
    • Open Surgical Biopsy
  • Vacuum-Assisted Biopsy Systems
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Specialty Clinics
  • Automation Level
    • Fully Automatic Systems
    • Manual Systems
    • Semi-Automatic Systems
  • Device Portability
    • Portable
    • Stationary
  • Needle Gauge
  • Magnetic Resonance Imaging (MRI)-Guided Biopsy
  • Mass Detection
  • Microcalcification
  • Stereotactic-Guided Biopsy
    • Computer-Aided Detection
    • Without Computer-Aid
  • Ultrasound-Guided Biopsy
  • Healthcare Practitioners
  • Physicians
  • Radiologists
  • Surgeons
  • Bioabsorbable
  • Polycarbonate
  • Stainless Steel
  • Titanium
  • Direct Sales
  • Distributors
  • Online Platforms
  • Invasive
  • Minimally Invasive
  • Radiofrequency
  • Ultrasound

This research report categorizes the Rotary-Cutting Biopsy System for Breast Lesion Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Rotary-Cutting Biopsy System for Breast Lesion Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company (BD)
  • Biocept, Inc.
  • C. R. Bard, Inc. (a BD Company)
  • Cardinal Health, Inc.
  • Cook Medical Incorporated
  • Danaher Corporation
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Konica Minolta, Inc.
  • Leica Biosystems Nussloch GmbH
  • Medtronic plc
  • Olympus Corporation
  • United Medical Equipment, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rotary-Cutting Biopsy System for Breast Lesion Market, by Biopsy System Type
8.1. Introduction
8.2. Core Needle Biopsy Systems
8.3. Excisional Biopsy Systems
8.4. Fine Needle Aspiration Biopsy Systems
8.5. Incisional Biopsy Systems
8.5.1. Closed Biopsy
8.5.2. Open Surgical Biopsy
8.6. Vacuum-Assisted Biopsy Systems
9. Rotary-Cutting Biopsy System for Breast Lesion Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Diagnostic Centers
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
9.5. Specialty Clinics
10. Rotary-Cutting Biopsy System for Breast Lesion Market, by Product Feature
10.1. Introduction
10.2. Automation Level
10.2.1. Fully Automatic Systems
10.2.2. Manual Systems
10.2.3. Semi-Automatic Systems
10.3. Device Portability
10.3.1. Portable
10.3.2. Stationary
10.4. Needle Gauge
11. Rotary-Cutting Biopsy System for Breast Lesion Market, by Application
11.1. Introduction
11.2. Magnetic Resonance Imaging (MRI)-Guided Biopsy
11.3. Mass Detection
11.4. Microcalcification
11.5. Stereotactic-Guided Biopsy
11.5.1. Computer-Aided Detection
11.5.2. Without Computer-Aid
11.6. Ultrasound-Guided Biopsy
12. Rotary-Cutting Biopsy System for Breast Lesion Market, by Customer Type
12.1. Introduction
12.2. Healthcare Practitioners
12.3. Physicians
12.4. Radiologists
12.5. Surgeons
13. Rotary-Cutting Biopsy System for Breast Lesion Market, by Material
13.1. Introduction
13.2. Bioabsorbable
13.3. Polycarbonate
13.4. Stainless Steel
13.5. Titanium
14. Rotary-Cutting Biopsy System for Breast Lesion Market, by Distribution Channel
14.1. Introduction
14.2. Direct Sales
14.3. Distributors
14.4. Online Platforms
15. Rotary-Cutting Biopsy System for Breast Lesion Market, by Procedure
15.1. Introduction
15.2. Invasive
15.3. Minimally Invasive
16. Rotary-Cutting Biopsy System for Breast Lesion Market, by Technology
16.1. Introduction
16.2. Radiofrequency
16.3. Ultrasound
17. Americas Rotary-Cutting Biopsy System for Breast Lesion Market
17.1. Introduction
17.2. Argentina
17.3. Brazil
17.4. Canada
17.5. Mexico
17.6. United States
18. Asia-Pacific Rotary-Cutting Biopsy System for Breast Lesion Market
18.1. Introduction
18.2. Australia
18.3. China
18.4. India
18.5. Indonesia
18.6. Japan
18.7. Malaysia
18.8. Philippines
18.9. Singapore
18.10. South Korea
18.11. Taiwan
18.12. Thailand
18.13. Vietnam
19. Europe, Middle East & Africa Rotary-Cutting Biopsy System for Breast Lesion Market
19.1. Introduction
19.2. Denmark
19.3. Egypt
19.4. Finland
19.5. France
19.6. Germany
19.7. Israel
19.8. Italy
19.9. Netherlands
19.10. Nigeria
19.11. Norway
19.12. Poland
19.13. Qatar
19.14. Russia
19.15. Saudi Arabia
19.16. South Africa
19.17. Spain
19.18. Sweden
19.19. Switzerland
19.20. Turkey
19.21. United Arab Emirates
19.22. United Kingdom
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. Argon Medical Devices, Inc.
20.3.2. Becton, Dickinson and Company (BD)
20.3.3. Biocept, Inc.
20.3.4. C. R. Bard, Inc. (a BD Company)
20.3.5. Cardinal Health, Inc.
20.3.6. Cook Medical Incorporated
20.3.7. Danaher Corporation
20.3.8. Devicor Medical Products, Inc.
20.3.9. F. Hoffmann-La Roche AG
20.3.10. Hologic, Inc.
20.3.11. Konica Minolta, Inc.
20.3.12. Leica Biosystems Nussloch GmbH
20.3.13. Medtronic plc
20.3.14. Olympus Corporation
20.3.15. United Medical Equipment, Inc.
21. ResearchAI
22. ResearchStatistics
23. ResearchContacts
24. ResearchArticles
25. Appendix
List of Figures
FIGURE 1. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET MULTI-CURRENCY
FIGURE 2. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET MULTI-LANGUAGE
FIGURE 3. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 24. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 28. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. EUROPE, MIDDLE EAST & AFRICA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 34. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CORE NEEDLE BIOPSY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY EXCISIONAL BIOPSY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CLOSED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY OPEN SURGICAL BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY VACUUM-ASSISTED BIOPSY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY FULLY AUTOMATIC SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY SEMI-AUTOMATIC SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATIONARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY NEEDLE GAUGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI)-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MASS DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MICROCALCIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COMPUTER-AIDED DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY WITHOUT COMPUTER-AID, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HEALTHCARE PRACTITIONERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PHYSICIANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY RADIOLOGISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY SURGEONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOABSORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TITANIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 107. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 108. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 111. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 112. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 113. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 115. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 116. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 117. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 119. CANADA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 122. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 125. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 126. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 127. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 129. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 130. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 169. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 170. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 179. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 180. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 183. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 184. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 185. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 187. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 188. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 189. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 191. CHINA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 193. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 194. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 197. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 198. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 199. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 201. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 202. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 203. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 205. INDIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 207. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 208. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 211. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 212. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 213. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 221. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 222. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 225. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 226. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 227. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 229. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 230. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 231. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 233. JAPAN ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 235. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 238. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 239. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 240. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 241. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 243. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 244. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 245. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PRODUCT FEATURE, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY AUTOMATION LEVEL, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DEVICE PORTABILITY, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY CUSTOMER TYPE, 2018-2030 (USD MILLION)
TABLE 258. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY BIOPSY SYSTEM TYPE, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE ROTARY-CUTTING BIOPSY SYSTEM FOR BREAST LESION MARKET SIZE, BY INCISIONAL BIOPSY SYSTEMS, 2018-2030

Companies Mentioned

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company (BD)
  • Biocept, Inc.
  • C. R. Bard, Inc. (a BD Company)
  • Cardinal Health, Inc.
  • Cook Medical Incorporated
  • Danaher Corporation
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Konica Minolta, Inc.
  • Leica Biosystems Nussloch GmbH
  • Medtronic plc
  • Olympus Corporation
  • United Medical Equipment, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

U.S. Breast Cancer Screening and Diagnostic Market: Analysis and Forecast, 2024-2030 - Product Image

U.S. Breast Cancer Screening and Diagnostic Market: Analysis and Forecast, 2024-2030

  • Report
  • 288 Pages
  • United States
From
Breast Cancer Diagnostics - Global Strategic Business Report - Product Image

Breast Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Cancer Diagnostic - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Cancer Diagnostic - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033 - Product Image

Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033

  • Report
  • 145 Pages
  • Global
From
Skin Cancer Diagnostics - Global Strategic Business Report - Product Image

Skin Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 64 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.